Arvee Laboratories (India) Ltd
Ticker: ARVEE
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
163.61
Market Cap
180.30
Debt/Equity
0.0344
ROE %
3.673
PB
6.1937
Promoter %
73.503
Pledge %
0.000
1Y Rev Growth %
26.299
5Y Rev Growth %
-3.081
NP Margin %
5.468
NP Margin 5Y Avg %
5.460
Trading Reference
1M Return %
4.719
6M Return %
14.661
1Y Return %
-7.643
% Away 52W High
38.347
% Away 52W Low
29.295
Daily Volume
1566
Investment Verdict
Avoid
Score 43/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 37/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Arvee Laboratories shows potential with steady growth but faces market challenges.
✅ Positives
- Consistent revenue growth over the past years
- Strong product portfolio in specialty chemicals
- Expanding into new markets and segments
⚠️ Negatives
- High competition in the chemical sector
- Vulnerability to raw material price fluctuations
- Regulatory challenges impacting operations
Verdict
Cautiously optimistic about future performance.
Recommendation: Consider a hold position for now.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
D
Ducon Infratechnologies Ltd
Ducon Infratechnologies Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in performance metrics.
View details
R
Ruchi Infrastructure Ltd
Ruchi Infrastructure Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
S
Shri Techtex Ltd
Shri Techtex Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
T
TBI Corn Ltd
TBI Corn Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
K
Kanchi Karpooram Ltd
Kanchi Karpooram Ltd presents a risky investment opportunity due to inconsistent growth and average profitability metrics, with concerns over valuation and market sentiment.
View details
R
Readymix Construction Machinery Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
P
PRO FX Tech Ltd
PRO FX Tech Ltd shows potential but faces challenges in growth consistency and market competition.
View details
S
Sumuka Agro Industries Ltd
Sumuka Agro Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Mangalam Industrial Finance Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
Kimia Biosciences Ltd
Kimia Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
HCP Plastene Bulkpack Ltd
HCP Plastene Bulkpack Ltd shows potential for growth with a decent business model, but faces challenges in execution and valuation metrics.
View details
L
Lancor Holdings Ltd
Lancor Holdings Ltd presents a risky investment due to inconsistent growth and weak market sentiment.
View details
G
GVP Infotech Ltd
GVP Infotech Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
T
Texmo Pipes and Products Ltd
Texmo Pipes and Products Ltd shows potential for growth but faces challenges in profitability and execution risks.
View details
W
Weizmann Limited
Weizmann Limited shows potential but faces challenges in growth consistency and market valuation.
View details
A
Available Finance Ltd
Available Finance Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation metrics.
View details
Business Overview
Arvee Laboratories (India) Ltd is a leading manufacturer and exporter of high-quality pharmaceutical products and active pharmaceutical ingredients (APIs). Catering primarily to the healthcare sector, the company is committed to innovation and excellence in its offerings. With a robust presence in both domestic and international markets, Arvee is dedicated to improving health outcomes and ensuring patient safety.
- Established leader in pharmaceutical manufacturing
- Focus on high-quality APIs and finished products
- Strong export capabilities to global markets
- Commitment to innovation and R&D
- Dedicated to enhancing healthcare standards in India
Investment Thesis
Arvee Laboratories presents a compelling investment opportunity driven by a strong promoter group with a proven track record, significant growth potential in digital services, and attractive valuations compared to its peers. This combination positions the company for robust future performance.
- Strong promoter credibility enhances investor confidence.
- Digital services segment poised for substantial growth.
- Valuation metrics indicate an attractive entry point.
- Robust financials support sustainable business expansion.
- Strategic initiatives align with market trends.
Opportunity vs Risk
Opportunities
- Strong growth in healthcare sector
- Expanding product portfolio
- Rising demand for pharmaceuticals
- Potential for international expansion
Risks ⚠️
- Regulatory challenges in India
- High competition in industry
- Dependence on key suppliers
- Fluctuating raw material costs
Peer Perspective
Arvee Laboratories trades at a discount to peers like Aarti Industries and Alkyl Amines, primarily due to margin volatility. A sustained improvement in margins could catalyze a rerating in its valuation.
Future Outlook
Arvee Laboratories is well-positioned for growth, leveraging its innovative product pipeline and expanding market presence, provided it maintains strong execution and cost control to navigate potential industry challenges.
AI FAQs for Retail Users
- Q: What does Arvee Laboratories do?A: Arvee Laboratories specializes in manufacturing and exporting pharmaceutical products, particularly bulk drugs and intermediates.
- Q: Is Arvee Laboratories listed on Indian stock exchanges?A: Yes, Arvee Laboratories is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
- Q: What factors influence Arvee Laboratories' stock price?A: Factors include company performance, market conditions, industry trends, and economic indicators.
- Q: How can I invest in Arvee Laboratories?A: You can invest by purchasing shares through a registered stockbroker or an online trading platform.
- Q: What are the risks of investing in Arvee Laboratories?A: Risks include market volatility, regulatory changes, and company-specific operational challenges.
📊 Stock Investment Checklist (100 Points)
Arvee Laboratories (India) Ltd • Updated: 2025-09-16 19:36:43
-
8BusinessHighThe sector is stable with moderate growth potential, but lacks a significant moat.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuating profit margins.
-
10ProfitabilityHighROE and ROCE are average, with OCF trailing net profit.
-
9ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodLimited growth catalysts and execution risks are present.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Arvee Laboratories presents several risks with inconsistent growth and average profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100